Otolaryngology Doctors in Fort Belvoir, VA Accepting Medicare

6 Otolaryngology doctors found. Showing 1 - 6

Jeffrey Martin Schafer, MD Otolaryngology - Otology & Neurotology Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Atammc - Dept Of Otolaryngology, Fort Belvoir, VA 22060 Phone: 571-231-2679

Charles Qiyao Yang, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3497

Dr. Scott B Roofe, MD Otolaryngology - Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: Fort Belvoir Community Hospital, Fort Belvoir, VA 22060 Phone: 571-231-2896

Dr. Colleen Frances Perez, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-2544

Naomi Will, D.O. Otolaryngology Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-2544

Dr. Charles Alexander Riley, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3224

News Archive

Commonly used anesthetic regimen appears to have no negative effects on the developing brain of the fetus

An anesthetic regimen commonly used during surgery on pregnant mothers appears to have no negative effects on the developing brain of the fetus, according to a new study on sheep conducted by Duke University Medical Center researchers.

ISCO enrolls first U.S.-based donor to establish clinical-grade human parthenogenetic stem cell bank

International Stem Cell Corporation has now enrolled the first U.S.-based donor in its program to establish a bank of clinical-grade human parthenogenetic stem cells (hpSCs) capable of being immune-matched to millions of patients.

New guidelines to emphasize safety of dental treatment during pregnancy

Spotlighting the importance of oral health care for expectant mothers, the California Dental Association Foundation has released new guidelines designed to emphasize the safety of dental treatment during pregnancy and ensure women the services they need.

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

The international research & development (R&D) consortium, AfriCoLeish, formed by six research organizations from East Africa and Europe, has launched a Phase III clinical study to address the extreme difficulty in treating visceral leishmaniasis (VL) in patients who also are HIV-positive.

Read more Medical News

› Verified 7 days ago